MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Cancer Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

7,379 results · 1 filter active ·
Results by year
20042025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
7,379 works in the cohort · of 4,299,418page 11 of 148

Labels cover 8 of 7,379 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 7,379 of 7,379 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Development and Cancer: At the Crossroads of Nodal and Notch Signaling
Luigi Strizzi, Katharine M. Hardy, Elisabeth A. Seftor, Fabrício F. Costa, Dawn A. Kirschmann, Richard E.B. Seftor +2 more
2009· review· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
90
citations
affunlabeled
Abstract S6-01: <i>PIK3CA</i> status in circulating tumor DNA (ctDNA) predicts efficacy of buparlisib (BUP) plus fulvestrant (FULV) in postmenopausal women with endocrine-resistant HR+/HER2– advanced breast cancer (BC): First results from the randomized, phase III BELLE-2 trial
J. Baselga, S-A. Im, Hiroji Iwata, M. Clemons, Yoshiaki Ito, Ahmad Awada +17 more
2016· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
88
citations
affunlabeled
Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) &amp;lt; 25: SWOG S1007 (RxPonder)
Kevin Kalinsky, William E. Barlow, Funda Meric‐Bernstam, Julie R. Gralow, Kathy S. Albain, Daniel F. Hayes +27 more
2021· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
88
citations
← previousnext →

How this was built: Screen · Findings · About